Gossamer Bio adopts 2023 inducement plan reserving 6.76M shares for new hires and amends bylaws

Gossamer Bio, Inc.

Board approved 2023 Inducement Plan with 6,762,279 common shares reserved for grants to new employees as material inducement to hire.
Plan substantially similar to 2019 Incentive Award Plan but no ISOs; adopted without stockholder approval per NASDAQ Rule 5635(c)(4).
Bylaws amended effective Nov 27, 2023 to address universal proxy rules under SEC Rule 14a-19 and enhance disclosure for stockholder nominations.
Amendments also include technical, modernizing and clarifying changes to the bylaws.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Gossamer Bio, Inc.: Amended and restated bylaws to address universal proxy rules and enhance procedural mechanics and disclosure requirements for stockholder nominations and proposals (effective 2023-11-27).

Change: bylaw amendment
Effective: 2023-11-27

Exact text from the filing

On November 27, 2023, the Board of Directors (the "Board") of the Company approved and adopted amended and restated bylaws (the “Amended and Restated Bylaws”), which became effective the same day.

View on SEC.gov

11 governance changes filed in the last 30 days. Browse all governance changes →

Gossamer Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001728117-23-000151

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.